Exocrine Pancreatic Insufficiency in Children – Challenges in Management

References

• Löhr JM, Dominguez-Munoz E, Rosendahl J, et al. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United Eur Gastroenterol j. 2017;5(2):153–199. doi:10.1177/2050640616684695
   PubMed Web of Science ®Google Scholar
• Bitton S, Pettei MJ. Exocrine pancreatic insufficiency. Pediatrics in Review. 2016;37(2):85–87. doi:10.1542/pir.2015-0084
   PubMedGoogle Scholar
• DiMagno EP, Go VL, Summerskill W. Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Eng J Med. 1973;288(16):813–815. doi:10.1056/NEJM197304192881603
   PubMed Web of Science ®Google Scholar
• Capurso G, Traini M, Piciucchi M, Signoretti M, Arcidiacono PG. Exocrine pancreatic insufficiency: prevalence, diagnosis, and management. Clin Exp Gastroenterol. 2019;129–139. doi:10.2147/CEG.S168266
   PubMed Web of Science ®Google Scholar
• Singh VK, Haupt ME, Geller DE, Hall JA, Diez PMQ. Less common etiologies of exocrine pancreatic insufficiency. World J Gastroenterol. 2017;23(39):7059. doi:10.3748/wjg.v23.i39.7059
   PubMed Web of Science ®Google Scholar
• Dominguez-Munoz JE, Drewes AM, Lindkvist B, et al. Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis. Pancreatology. 2018;18(8):847–854. doi:10.1016/j.pan.2018.09.016
   PubMed Web of Science ®Google Scholar
• Shimizu K, Ito T, Irisawa A, et al. Evidence-based clinical practice guidelines for chronic pancreatitis 2021. J Gastroenterol. 2022;57(10):709–724. doi:10.1007/s00535-022-01911-6
   PubMed Web of Science ®Google Scholar
• Phillips ME, Hopper AD, Leeds JS, et al. Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelines. BMJ open Gastroenterol. 2021;8(1):e000643. doi:10.1136/bmjgast-2021-000643
   PubMed Web of Science ®Google Scholar
• Toouli J, Biankin AV, Oliver MR, Pearce CB, Wilson JS, Wray NH. Management of pancreatic exocrine insufficiency: Australasian Pancreatic Club recommendations. Med j Australia. 2010;193(8):461–467. doi:10.5694/j.1326-5377.2010.tb04000.x
   PubMed Web of Science ®Google Scholar
• Sabater L, Ausania F, Bakker OJ, et al. Evidence-based guidelines for the management of exocrine pancreatic insufficiency after pancreatic surgery. Ann Surg. 2016;264(6):949–958. doi:10.1097/SLA.0000000000001732
   PubMed Web of Science ®Google Scholar
• Gardner TB, Adler DG, Forsmark CE, Sauer BG, Taylor JR, Whitcomb DC. ACG clinical guideline: chronic pancreatitis. Official j Am Coll Gastroenterol ACG. 2020;115(3):322–339. doi:10.14309/ajg.0000000000000535
   PubMed Web of Science ®Google Scholar
• Forsmark CE. Diagnosis and management of exocrine pancreatic insufficiency. Curr Treat Options Gastroenterol. 2018;16(3):306–315. doi:10.1007/s11938-018-0186-y
   PubMedGoogle Scholar
• Uc A, Fishman DS. Pancreatic disorders. Pediatric Clin. 2017;64(3):685–706. doi:10.1016/j.pcl.2017.01.010
   PubMed Web of Science ®Google Scholar
• Gheorghe C, Seicean A, Saftoiu A, et al. Romanian guidelines on the diagnosis and treatment of exocrine pancreatic insufficiency. J Gastrointestin Liver Dis. 2015;24(1):117–123. doi:10.15403/jgld.2014.1121.app
   PubMed Web of Science ®Google Scholar
• Sankararaman S, Schindler T, Sferra TJ. Management of Exocrine Pancreatic Insufficiency in Children. Nutrition Clin Practice. 2019;34(S1):S27–S42. doi:10.1002/ncp.10388
   PubMedGoogle Scholar
• Stormon MO, Durie PR. Pathophysiologic basis of exocrine pancreatic dysfunction in childhood. J Pediatr Gastroenterol Nutr. 2002;35(1):8–21. doi:10.1097/00005176-200207000-00004
   PubMed Web of Science ®Google Scholar
• Taylor CJ, Chen K, Horvath K, et al. ESPGHAN and NASPGHAN report on the assessment of exocrine pancreatic function and pancreatitis in children. J Pediatr Gastroenterol Nutr. 2015;61(1):144–153. doi:10.1097/MPG.0000000000000830
   PubMed Web of Science ®Google Scholar
• Sturgess JM. Structural and developmental abnormalities of the exocrine pancreas in cystic fibrosis. J Pediatr Gastroenterol Nutr. 1984;3:S55–66. doi:10.1097/00005176-198400031-00011
   PubMedGoogle Scholar
• Wilschanski M, Durie PR. Patterns of GI disease in adulthood associated with mutations in the CFTR gene. Gut. 2007;56(8):1153–1163. doi:10.1136/gut.2004.062786
   PubMed Web of Science ®Google Scholar
• Freedman SD, Blanco P, Shea JC, Alvarez JG. Mechanisms to explain pancreatic dysfunction in cystic fibrosis. Med Clin North Am. 2000;84(3):657–664. doi:10.1016/S0025-7125(05)70248-0
   PubMed Web of Science ®Google Scholar
• Cystic Fibrosis Foundation, 2021 Patient Registry Annual Data Report. Available from: https://www.cff.org/Research/Researcher-Resources/Patient-Registry. Accessed September 9, 2023.
   Google Scholar
• Guy-Crotte O, Carrère J, Figarella C. Exocrine pancreatic function in cystic fibrosis. Eur J Gastroenterol Hepatol. 1996;8(8):755–759.
   PubMed Web of Science ®Google Scholar
• Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell. 1993;73(7):1251–1254. doi:10.1016/0092-8674(93)90353-R
   PubMed Web of Science ®Google Scholar
• Gaskin K. Nutritional care in children with cystic fibrosis: are our patients becoming better? Eur J Clin Nutr. 2013;67(5):558–564. doi:10.1038/ejcn.2013.20
   PubMed Web of Science ®Google Scholar
• Altman K, McDonald CM, Michel SH, Maguiness K. Nutrition in cystic fibrosis: from the past to the present and into the future. Pediatr Pulmonol. 2019;54(S3):S56–S73. doi:10.1002/ppul.24521
   PubMedGoogle Scholar
• Southern KW, Munck A, Pollitt R, et al. A survey of newborn screening for cystic fibrosis in Europe. J Cystic Fibrosis. 2007;6(1):57–65. doi:10.1016/j.jcf.2006.05.008
   PubMed Web of Science ®Google Scholar
• Salvatore D, Buzzetti R, Baldo E, et al. An overview of international literature from cystic fibrosis registries. Part 3. Disease incidence, genotype/phenotype correlation, microbiology, pregnancy, clinical complications, lung transplantation, and miscellanea. J Cystic Fibrosis. 2011;10(2):71–85. doi:10.1016/j.jcf.2010.12.005
   PubMed Web of Science ®Google Scholar
• Hollander FM, de Roos NM, Heijerman HG. The optimal approach to nutrition and cystic fibrosis: latest evidence and recommendations. Curr Opin Pulm Med. 2017;23(6):556–561. doi:10.1097/MCP.0000000000000430
   PubMed Web of Science ®Google Scholar
• Andersen DH. Cystic fibrosis of the pancreas and its relation to celiac disease: a clinical and pathologic study. Am j Dis Children. 1938;56(2):344–399. doi:10.1001/archpedi.1938.01980140114013
   Google Scholar
• Gorter R, Karimi A, Sleeboom C, Kneepkens C, Heij H. Clinical and genetic characteristics of meconium ileus in newborns with and without cystic fibrosis. J Pediatr Gastroenterol Nutr. 2010;50(5):569–572. doi:10.1097/MPG.0b013e3181bb3427
   PubMed Web of Science ®Google Scholar
• Cade A, Walters M, McGinley N, et al. Evaluation of fecal pancreatic elastase‐1 as a measure of pancreatic exocrine function in children with cystic fibrosis. Pediatr Pulmonol. 2000;29(3):172–176. doi:10.1002/(SICI)1099-0496(200003)29:3<172::AID-PPUL3>3.0.CO;2-1
   PubMed Web of Science ®Google Scholar
• Dror Y, Donadieu J, Koglmeier J, et al. Draft consensus guidelines for diagnosis and treatment of Shwachman‐Diamond syndrome. Ann N Y Acad Sci. 2011;1242(1):40–55. doi:10.1111/j.1749-6632.2011.06349.x
   PubMedGoogle Scholar
• Myers KC, Bolyard AA, Otto B, et al. Variable clinical presentation of Shwachman–Diamond syndrome: update from the North American Shwachman–Diamond syndrome registry. J Pediatr. 2014;164(4):866–870. doi:10.1016/j.jpeds.2013.11.039
   PubMed Web of Science ®Google Scholar
• Myers KC, Davies SM, Shimamura A. Clinical and molecular pathophysiology of Shwachman–Diamond syndrome: an update. Hematology/Oncol Clin. 2013;27(1):117–128. doi:10.1016/j.hoc.2012.10.003
   PubMed Web of Science ®Google Scholar
• Mack DR, Forstner GG, Wilschanski M, Freedman MH, Durie PR. Shwachman syndrome: exocrine pancreatic dysfunction and variable phenotypic expression. Gastroenterology. 1996;111(6):1593–1602. doi:10.1016/S0016-5085(96)70022-7
   PubMed Web of Science ®Google Scholar
• Nelson AS, Myers KC. Diagnosis, treatment, and molecular pathology of Shwachman-Diamond syndrome. Hematology/Oncol Clin. 2018;32(4):687–700. doi:10.1016/j.hoc.2018.04.006
   PubMed Web of Science ®Google Scholar
• Ginzberg H, Shin J, Ellis L, et al. Shwachman syndrome: phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar. J Pediatr. 1999;135(1):81–88. doi:10.1016/S0022-3476(99)70332-X
   PubMed Web of Science ®Google Scholar
• Cipolli M. Shwachman-Diamond syndrome: clinical phenotypes. Pancreatology. 2001;1(5):543–548. doi:10.1159/000055858
   PubMed Web of Science ®Google Scholar
• Ikuse T, Kudo T, Arai K, et al. Shwachman–Diamond syndrome: nationwide survey and systematic review in Japan. Pediatrics Int. 2018;60(8):719–726. doi:10.1111/ped.13601
   PubMed Web of Science ®Google Scholar
• Goobie S, Popovic M, Morrison J, et al. Shwachman-Diamond syndrome with exocrine pancreatic dysfunction and bone marrow failure maps to the centromeric region of chromosome 7. Am J Human Genetics. 2001;68(4):1048–1054. doi:10.1086/319505
   PubMed Web of Science ®Google Scholar
• Boocock GR, Morrison JA, Popovic M, et al. Mutations in SBDS are associated with Shwachman–Diamond syndrome. Nat Genet. 2003;33(1):97–101. doi:10.1038/ng1062
   PubMed Web of Science ®Google Scholar
• Shwachman H, Diamond LK, Oski FA, Khaw K-T. The syndrome of pancreatic insufficiency and bone marrow dysfunction. J Pediatr. 1964;65(5):645–663. doi:10.1016/S0022-3476(64)80150-5
   PubMed Web of Science ®Google Scholar
• Finch AJ, Hilcenko C, Basse N, et al. Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome. Genes Dev. 2011;25(9):917–929. doi:10.1101/gad.623011
   PubMed Web of Science ®Google Scholar
• Nijs E, Callahan MJ, Taylor GA. Disorders of the pediatric pancreas: imaging features. Pediatr Radiol. 2005;35(4):358–373. doi:10.1007/s00247-004-1326-1
   PubMed Web of Science ®Google Scholar
• Johanson A, Blizzard R. A syndrome of congenital aplasia of the alae nasi, deafness, hypothyroidism, dwarfism, absent permanent teeth, and malabsorption. J Pediatr. 1971;79(6):982–987. doi:10.1016/S0022-3476(71)80194-4
   PubMed Web of Science ®Google Scholar
• Civelek Z, Urganci N, Usta M, Celik M. A rare cause of pancreatic insufficiency; Johanson Blizzard Syndrome. J Pak Med Assoc. 2018;68(5):801–803.
   PubMed Web of Science ®Google Scholar
• Almashraki N, Abdulnabee MZ, Sukalo M, Alrajoudi A, Sharafadeen I, Zenker M. Johanson-Blizzard syndrome. World J Gastroenterol. 2011;17(37):4247. doi:10.3748/wjg.v17.i37.4247
   PubMed Web of Science ®Google Scholar
• Zenker M, Mayerle J, Lerch MM, et al. Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway, causes pancreatic dysfunction, malformations and mental retardation (Johanson-Blizzard syndrome). Nat Genet. 2005;37(12):1345–1350. doi:10.1038/ng1681
   PubMed Web of Science ®Google Scholar
• Scheers I, Berardis S. Congenital etiologies of exocrine pancreatic insufficiency. Front Pediatrics. 2022;10:909925. doi:10.3389/fped.2022.909925
   PubMed Web of Science ®Google Scholar
• Jones NL, Hofley PM, Durie PR. Pathophysiology of the pancreatic defect in Johanson-Blizzard syndrome: a disorder of acinar development. J Pediatr. 1994;125(3):406–408. doi:10.1016/S0022-3476(05)83286-X
   PubMed Web of Science ®Google Scholar
• Cano DA, Hebrok M, Zenker M. Pancreatic development and disease. Gastroenterology. 2007;132(2):745–762. doi:10.1053/j.gastro.2006.12.054
   PubMed Web of Science ®Google Scholar
• Liu S, Wang Z, Jiang J, et al. Severe forms of Johanson-Blizzard syndrome caused by two novel compound heterozygous variants in UBR1: clinical manifestations, imaging findings and molecular genetics. Pancreatology. 2020;20(3):562–568. doi:10.1016/j.pan.2020.01.007
   PubMed Web of Science ®Google Scholar
• Reynolds E, Byrne M, Ganetzky R, Parikh S. Pediatric single large-scale mtDNA deletion syndromes: the power of patient reported outcomes. Mol Genet Metab. 2021;134(4):301–308. doi:10.1016/j.ymgme.2021.11.004
   PubMed Web of Science ®Google Scholar
• Yoshimi A, Ishikawa K, Niemeyer C, Grünert SC. Pearson syndrome: a multisystem mitochondrial disease with bone marrow failure. Orphanet J Rare Dis. 2022;17(1):1–11. doi:10.1186/s13023-022-02538-9
   PubMed Web of Science ®Google Scholar
• Pronman L, Rondinelli M, Burkardt DDC, Velayuthan S, Khalili AS, Bedoyan JK. Pearson syndrome: a rare cause of failure to thrive in infants. Clin Pediatr (Phila). 2019;58(7):819–824. doi:10.1177/0009922819834285
   PubMed Web of Science ®Google Scholar
• Rötig A, Bourgeron T, Chretien D, Rustin P, Munnich A. Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome. Hum Mol Genet. 1995;4(8):1327–1330. doi:10.1093/hmg/4.8.1327
   PubMed Web of Science ®Google Scholar
• Pearson HA, Lobel JS, Kocoshis SA, et al. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr. 1979;95(6):976–984. doi:10.1016/S0022-3476(79)80286-3
   PubMed Web of Science ®Google Scholar
• Rotig A, Colonna M, Bonnefont J, et al. Mitochondrial DNA deletion in Pearson’s marrow/pancreas syndrome. Lancet. 1989;333(8643):902–903. doi:10.1016/S0140-6736(89)92897-3
   Google Scholar
• Jeune BC, Carron R. Dystrophie thoracique asphyxiante de caractère familial. Arch Fr Pediatr. 1955;12:866–891.
   Google Scholar
• De Vries J, Yntema J, Van Die C, Crama N, Cornelissen E, Hamel B. Jeune syndrome: description of 13 cases and a proposal for follow-up protocol. Eur J Pediatr. 2010;169(1):77. doi:10.1007/s00431-009-0991-3
   PubMed Web of Science ®Google Scholar
• Karjoo M, Koop CE, Cornfeld D, Holtzapple PG. Pancreatic exocrine enzyme deficiency associated with asphyxiating thoracic dystrophy. Arch Dis Child. 1973;48(2):143. doi:10.1136/adc.48.2.143
   PubMed Web of Science ®Google Scholar
• Turkel S, Diehl E, Richmond J. Necropsy findings in neonatal asphyxiating thoracic dystrophy. J Med Genet. 1985;22(2):112–118. doi:10.1136/jmg.22.2.112
   PubMed Web of Science ®Google Scholar
• Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet. 1997;15(1):106–110. doi:10.1038/ng0197-106
   PubMed Web of Science ®Google Scholar
• Thomas IH, Saini NK, Adhikari A, et al. Neonatal diabetes mellitus with pancreatic agenesis in an infant with homozygous IPF‐1 Pro63fsX60 mutation. Pediatr Diabetes. 2009;10(7):492–496. doi:10.1111/j.1399-5448.2009.00526.x
   PubMed Web of Science ®Google Scholar
• Nicolino M, Claiborn KC, Senée V, Boland A, Stoffers DA, Julier C. A novel hypomorphic PDX1 mutation responsible for permanent neonatal diabetes with subclinical exocrine deficiency. Diabetes. 2010;59(3):733–740. doi:10.2337/db09-1284
   PubMed Web of Science ®Google Scholar
• Wright NM, Metzger DL, Borowitz SM, Clarke WL. Permanent neonatal diabetes mellitus and pancreatic exocrine insufficiency resulting from congenital pancreatic agenesis. Am j Dis Children. 1993;147(6):607–609. doi:10.1001/archpedi.1993.02160300013005
   PubMedGoogle Scholar
• Winter WE, Maclaren NK, Riley WJ, Toskes PP, Andres J, Rosenbloom AL. Congenital pancreatic hypoplasia: a syndrome of exocrine and endocrine pancreatic insufficiency. J Pediatr. 1986;109(3):465–468. doi:10.1016/S0022-3476(86)80119-6
   PubMed Web of Science ®Google Scholar
• Sellick GS, Barker KT, Stolte-Dijkstra I, et al. Mutations in PTF1A cause pancreatic and cerebellar agenesis. Nat Genet. 2004;36(12):1301–1305. doi:10.1038/ng1475
   PubMed Web of Science ®Google Scholar
• Al‐Shammari M, Al‐Husain M, Al‐Kharfy T, Alkuraya FS. A novel PTF1A mutation in a patient with severe pancreatic and cerebellar involvement. Clin Genet. 2011;80(2):196–198. doi:10.1111/j.1399-0004.2010.01613.x
   PubMed Web of Science ®Google Scholar
• Hoveyda N, Shield JP, Garrett C, et al. Neonatal diabetes mellitus and cerebellar hypoplasia/agenesis: report of a new recessive syndrome. J Med Genet. 1999;36(9):700–704.
   PubMed Web of Science ®Google Scholar
• Allen HL, Flanagan SE, Shaw-Smith C, et al. GATA6 haploinsufficiency causes pancreatic agenesis in humans. Nat Genet. 2012;44(1):20–22. doi:10.1038/ng.1035
   Web of Science ®Google Scholar
• Balasubramanian M, Shield J, Acerini C, et al. Pancreatic hypoplasia presenting with neonatal diabetes mellitus in association with congenital heart defect and developmental delay. Am J Med Genet A. 2010;152(2):340–346. doi:10.1002/ajmg.a.33194
   Google Scholar
• Yorifuji T, Kawakita R, Hosokawa Y, Fujimaru R, Yamaguchi E, Tamagawa N. Dominantly inherited diabetes mellitus caused by GATA6 haploinsufficiency: variable intrafamilial presentation. J Med Genet. 2012;49(10):642–643. doi:10.1136/jmedgenet-2012-101161
   PubMed Web of Science ®Google Scholar
• Shteyer E, Saada A, Shaag A, Kidess R, Revel-Vilk S, Elpeleg O. Exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis are caused by a mutation in the COX4I2 gene. Am J Human Genetics. 2009;84(3):412–417. doi:10.1016/j.ajhg.2009.02.006
   PubMed Web of Science ®Google Scholar
• Behar DM, Basel-Vanagaite L, Glaser F, et al. Identification of a novel mutation in the PNLIP gene in two brothers with congenital pancreatic lipase deficiency. J Lipid Res. 2014;55(2):307–312. doi:10.1194/jlr.P041103
   PubMed Web of Science ®Google Scholar
• Sheldon W. Congenital pancreatic lipase deficiency. Arch Dis Child. 1964;39(205):268. doi:10.1136/adc.39.205.268
   PubMed Web of Science ®Google Scholar
• Figarella C, De Caro A, Leupold D, Poley J. Congenital pancreatic lipase deficiency. J Pediatr. 1980;96(3):412–416. doi:10.1016/S0022-3476(80)80683-4
   PubMed Web of Science ®Google Scholar
• Ligumsky M, Granot E, Branski D, Stankiewicz H, Goldstein R. Isolated lipase and colipase deficiency in two brothers. Gut. 1990;31(12):1416–1418. doi:10.1136/gut.31.12.1416
   PubMed Web of Science ®Google Scholar
• Figarella C, Negri GA, Sarles H. Presence of colipase in a congenital pancreatic lipase deficiency. Biochimica et Biophysica Acta. 1972;280(1):205–210. doi:10.1016/0005-2760(72)90227-5
   PubMedGoogle Scholar
• Ghishan FK, Moran JR, Durie PR, Greene HL. Isolated congenital lipase—colipase deficiency. Gastroenterology. 1984;86(6):1580–1582. doi:10.1016/S0016-5085(84)80175-4
   PubMed Web of Science ®Google Scholar
• Szabó A, Xiao X, Haughney M, Spector A, Sahin-Tóth M, Lowe ME. A novel mutation in PNLIP causes pancreatic triglyceride lipase deficiency through protein misfolding. Biochim Biophys Acta. 2015;1852(7):1372–1379. doi:10.1016/j.bbadis.2015.04.002
   PubMed Web of Science ®Google Scholar
• Hildebrand H, Borgström B, Bekassy A, Erlanson-Albertsson C, Helin I. Isolated co-lipase deficiency in two brothers. Gut. 1982;23(3):243–246. doi:10.1136/gut.23.3.243
   PubMed Web of Science ®Google Scholar
• Davis RC, Xia Y, Mohandas T, Schotz MC, Lusis AJ. Assignment of the human pancreatic colipase gene to chromosome 6p21. 1 to pter. Genomics. 1991;10(1):262–265. doi:10.1016/0888-7543(91)90509-D
   PubMed Web of Science ®Google Scholar
• Townes PL. Trypsinogen deficiency disease. J Pediatr. 1965;66(2):275–285. doi:10.1016/S0022-3476(65)80184-6
   PubMed Web of Science ®Google Scholar
• Townes PL, Bryson MF, Miller G. Further observations on trypsinogen deficiency disease: report of a second case. J Pediatr. 1967;71(2):220–224. doi:10.1016/S0022-3476(67)80076-3
   Web of Science ®Google Scholar
• Townes PL. Trypsinogen deficiency and other proteolytic deficiency disease. Bi Defects OAS. 1972;7(2):95–101.
   Google Scholar
• Holzinger A, Maier EM, Bück C, et al. Mutations in the proenteropeptidase gene are the molecular cause of congenital enteropeptidase deficiency. Am J Human Genetics. 2002;70(1):20–25. doi:10.1086/338456
   PubMed Web of Science ®Google Scholar
• Haworth J, Gourley B, Hadorn B, Sumida C. Malabsorption and growth failure due to intestinal enterokinase deficiency. J Pediatr. 1971;78(3):481–490. doi:10.1016/S0022-3476(71)80231-7
   PubMed Web of Science ®Google Scholar
• Ghishan FK, Lee P, Lebenthal E, Johnson P, Bradley CA, Greene HL. Isolated congenital enterokinase deficiency: recent findings and review of the literature. Gastroenterology. 1983;85(3):727–731. doi:10.1016/0016-5085(83)90033-1
   PubMed Web of Science ®Google Scholar
• Hadorn B, Tarlow M, Lloyd J, Wolff O. Intestinal enterokinase deficiency. Lancet. 1969;1(7599):812–813. doi:10.1016/S0140-6736(69)92071-6
   PubMed Web of Science ®Google Scholar
• Bartels RH, Meyer SL, Stehmann TA, Bourdon C, Bandsma RH, Voskuijl WP. Both exocrine pancreatic insufficiency and signs of pancreatic inflammation are prevalent in children with complicated severe acute malnutrition: an observational study. J Pediatr. 2016;174:165–170. doi:10.1016/j.jpeds.2016.04.013
   PubMed Web of Science ®Google Scholar
• Freeman AJ, Maqbool A, Bellin MD, et al. Medical Management of Chronic Pancreatitis in Children: a Position Paper by the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Pancreas Committee. J Pediatr Gastroenterol Nutr. 2021;72(2):324–340. doi:10.1097/MPG.0000000000003001
   PubMed Web of Science ®Google Scholar
• Hadorn B, Zoppi G, Shmerling D, Prader A, McIntyre I, Anderson CM. Quantitative assessment of exocrine pancreatic function in infants and children. J Pediatr. 1968;73(1):39–50. doi:10.1016/S0022-3476(68)80037-X
   PubMed Web of Science ®Google Scholar
• Freed LM, York CM, Hamosh P, Mehta NR, Hamosh M. Bile salt-stimulated lipase of human milk: characteristics of the enzyme in the milk of mothers of premature and full-term infants. J Pediatr Gastroenterol Nutr. 1987;6(4):598–604. doi:10.1097/00005176-198707000-00019
   PubMed Web of Science ®Google Scholar
• Haaber AB, Rosenfalck A, Hansen B, Hilsted J, Larsen S. Bone mineral metabolism, bone mineral density, and body composition in patients with chronic pancreatitis and pancreatic exocrine insufficiency. Int J Pancreatol. 2000;27(1):21–27. doi:10.1385/IJGC:27:1:21
   PubMedGoogle Scholar
• Borowitz D, Robinson KA, Rosenfeld M, et al. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr. 2009;155(6):S73–S93. doi:10.1016/j.jpeds.2009.09.001
   PubMed Web of Science ®Google Scholar
• Rings EH, Minich DM, Vonk RJ, Stellaard F, Fetter WP, Verkade HJ. Functional development of fat absorption in term and preterm neonates strongly correlates with ability to absorb long-chain fatty acids from intestinal lumen. Pediatr Res. 2002;51(1):57–63. doi:10.1203/00006450-200201000-00011
   PubMed Web of Science ®Google Scholar
• Horvath K, Mehta DI, Hill ID. Assessment of exocrine pancreatic function during endoscopy in children. J Pediatr Gastroenterol Nutr. 2019;68(6):768–776. doi:10.1097/MPG.0000000000002230
   PubMed Web of Science ®Google Scholar
• Daftary A, Acton J, Heubi J, Amin R. Fecal elastase-1: utility in pancreatic function in cystic fibrosis. J Cystic Fibrosis. 2006;5(2):71–76. doi:10.1016/j.jcf.2006.01.005
   PubMed Web of Science ®Google Scholar
• Khan A, Vege SS, Dudeja V, Chari ST. Staging exocrine pancreatic dysfunction. Pancreatology. 2022;22(1):168–172. doi:10.1016/j.pan.2021.11.005
   PubMed Web of Science ®Google Scholar
• Walkowiak J, Sands D, Nowakowska A, et al. Early decline of pancreatic function in cystic fibrosis patients with class 1 or 2 CFTR mutations. J Pediatr Gastroenterol Nutr. 2005;40(2):199–201. doi:10.1097/00005176-200502000-00022
   PubMed Web of Science ®Google Scholar
• Vanga RR, Tansel A, Sidiq S, El-Serag HB, Othman MO. Diagnostic performance of measurement of fecal elastase-1 in detection of exocrine pancreatic insufficiency: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16(8):1220–1228. e1224. doi:10.1016/j.cgh.2018.01.027
   PubMed Web of Science ®Google Scholar
• Domínguez-Muñoz JE, Nieto L, Vilariño M, Lourido MV, Iglesias-García J. Development and diagnostic accuracy of a breath test for pancreatic exocrine insufficiency in chronic pancreatitis. Pancreas. 2016;45(2):241–247. doi:10.1097/MPA.0000000000000434
   PubMed Web of Science ®Google Scholar
• Patel N, Sellers ZM, Grover A, et al. Endoscopic pancreatic function testing (ePFT) in children: a position paper from the NASPGHAN pancreas committee. J Pediatr Gastroenterol Nutr. 2021;72(1):144–150. doi:10.1097/MPG.0000000000002931
   PubMed Web of Science ®Google Scholar
• Cruz LA, Parniczky A, Mayhew A, et al. Utility of direct pancreatic function testing in children. Pancreas. 2017;46(2):177–182. doi:10.1097/MPA.0000000000000724
   PubMed Web of Science ®Google Scholar
• Swensson J, Zaheer A, Conwell D, Sandrasegaran K, Manfredi R, Tirkes T. Secretin-enhanced MRCP: how and why—AJR expert panel narrative review. AJR Am J Roentgenol. 2021;216(5):1139. doi:10.2214/AJR.20.24857
   PubMed Web of Science ®Google Scholar
• Hopson P, Smadi Y, Mehta V, Patel S, Mehta D, Horvath K. Assessment of exocrine pancreatic function in children and adolescents with direct and indirect testing. Front Pediatrics. 2022;10:908542. doi:10.3389/fped.2022.908542
   PubMed Web of Science ®Google Scholar
• Turck D, Braegger CP, Colombo C, et al. ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis. Clin Nutrition. 2016;35(3):557–577. doi:10.1016/j.clnu.2016.03.004
   PubMed Web of Science ®Google Scholar
• Borowitz DS, Grand RJ, Durie PR. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. J Pediatr. 1995;127(5):681–684. doi:10.1016/S0022-3476(95)70153-2
   PubMed Web of Science ®Google Scholar
• Borowitz D, Gelfond D, Maguiness K, Heubi JE, Ramsey B. Maximal daily dose of pancreatic enzyme replacement therapy in infants with cystic fibrosis: a reconsideration. J Cystic Fibrosis. 2013;12(6):784–785. doi:10.1016/j.jcf.2013.05.011
   PubMed Web of Science ®Google Scholar
• Gelfond D, Heltshe SL, Skalland M, et al. Pancreatic enzyme replacement therapy use in infants with cystic fibrosis diagnosed by newborn screening. J Pediatr Gastroenterol Nutr. 2018;66(4):657. doi:10.1097/MPG.0000000000001829
   PubMed Web of Science ®Google Scholar
• Singh VK, Schwarzenberg SJ. Pancreatic insufficiency in cystic fibrosis. J Cystic Fibrosis. 2017;16:S70–S78. doi:10.1016/j.jcf.2017.06.011
   PubMed Web of Science ®Google Scholar
• Smyth RL, Smyth A, Lloyd D, van Velzen D, Heaf DP. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet. 1994;343(8889):85–86. doi:10.1016/S0140-6736(94)90817-6
   PubMed Web of Science ®Google Scholar
• FitzSimmons SC, Burkhart GA, Borowitz D, et al. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Eng J Med. 1997;336(18):1283–1289. doi:10.1056/NEJM199705013361803
   PubMed Web of Science ®Google Scholar
• Smyth R, O’Hea U, Burrows E, et al. Fibrosing colonopathy in cystic fibrosis: results of a case-control study. Lancet. 1995;346(8985):1247–1251. doi:10.1016/S0140-6736(95)91860-4
   PubMed Web of Science ®Google Scholar
• Konrad J, Eber E, Stadlbauer V. Changing paradigms in the treatment of gastrointestinal complications of cystic fibrosis in the era of cystic fibrosis transmembrane conductance regulator modulators. Paediatr Respir Rev. 2022;42:9–16. doi:10.1016/j.prrv.2020.12.001
   PubMed Web of Science ®Google Scholar
• Schwarzenberg SJ, Hempstead SE, McDonald CM, et al. Enteral tube feeding for individuals with cystic fibrosis: cystic Fibrosis Foundation evidence-informed guidelines. J Cystic Fibrosis. 2016;15(6):724–735. doi:10.1016/j.jcf.2016.08.004
   PubMed Web of Science ®Google Scholar
• Saxby PC, Kench A, King S, Crowder T, van der Haak N. CFNGAG. Nutrition Guidelines for Cystic Fibrosis in Australia and New Zealand. In: Bell SC, editor.Thoracic Society of Australia and New Zealand.Sydney;2017.
   Google Scholar
• Schwarzenberg SJ, Borowitz D. Challenging barriers to an option for improved provision of enteral nutrition. J Cystic Fibrosis. 2019;18(4):447–449. doi:10.1016/j.jcf.2019.06.002
   PubMed Web of Science ®Google Scholar
• Freedman S, Orenstein D, Black P, et al. Increased fat absorption from enteral formula through an in-line digestive cartridge in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2017;65(1):97–101. doi:10.1097/MPG.0000000000001617
   PubMed Web of Science ®Google Scholar
• Stevens J, Wyatt C, Brown P, Patel D, Grujic D, Freedman SD. Absorption and safety with sustained use of RELiZORB evaluation (ASSURE) study in patients with cystic fibrosis receiving enteral feeding. J Pediatr Gastroenterol Nutr. 2018;67(4):527. doi:10.1097/MPG.0000000000002110
   PubMed Web of Science ®Google Scholar
• Available from: https://www.cff.org/Life-With-CF/Daily-Life/Fitness-and-Nutrition/Nutrition/Getting-Your-Nutrients/Vitamin-Comparison-Chart-for-CF-Specific-Multivitamins.pdf. Accessed February 27, 2021.
   Google Scholar
• Gelfond D, Ma C, Semler J, Borowitz D. Intestinal pH and gastrointestinal transit profiles in cystic fibrosis patients measured by wireless motility capsule. Dig Dis Sci. 2013;58(8):2275–2281. doi:10.1007/s10620-012-2209-1
   PubMed Web of Science ®Google Scholar
• Konstan MW, Accurso FJ, Nasr SZ, Ahrens RC, Graff GR. Efficacy and safety of a unique enteric-coated bicarbonate-buffered pancreatic enzyme replacement therapy in children and adults with cystic fibrosis. Clin Investig (Lond). 2013;3(8):723. doi:10.4155/cli.13.62
   PubMedGoogle Scholar
• van der Haak N, King SJ, Crowder T, Kench A, Painter C, Saxby N. Highlights from the nutrition guidelines for cystic fibrosis in Australia and New Zealand. J Cystic Fibrosis. 2020;19(1):16–25. doi:10.1016/j.jcf.2019.05.007
   PubMed Web of Science ®Google Scholar
• Couper R, Corey M, Durie P, Forstner G, Moore D. Longitudinal evaluation of serum trypsinogen measurement in pancreatic-insufficient and pancreatic-sufficient patients with cystic fibrosis. J Pediatr. 1995;127(3):408–413. doi:10.1016/S0022-3476(95)70072-2
   PubMed Web of Science ®Google Scholar
• Sergeev V, Chou FY, Lam GY, Hamilton CM, Wilcox PG, Quon BS. The extrapulmonary effects of cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis. Ann Am Thorac Soc. 2020;17(2):147–154. doi:10.1513/AnnalsATS.201909-671CME
   PubMed Web of Science ®Google Scholar
• De Boeck K, Weren M, Proesmans M, Kerem E. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. Pediatrics. 2005;115(4):e463–e469. doi:10.1542/peds.2004-1764
   PubMed Web of Science ®Google Scholar
• Corey M, McLaughlin F, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol. 1988;41(6):583–591. doi:10.1016/0895-4356(88)90063-7
   PubMed Web of Science ®Google Scholar
• Farrell PM, Kosorok MR, Rock MJ, et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Pediatrics. 2001;107(1):1–13. doi:10.1542/peds.107.1.1
   PubMed Web of Science ®Google Scholar
• Kumar S, Ooi CY, Werlin S, et al. Risk factors associated with pediatric acute recurrent and chronic pancreatitis: lessons from INSPPIRE. JAMA Pediatr. 2016;170(6):562–569. doi:10.1001/jamapediatrics.2015.4955
   PubMed Web of Science ®Google Scholar
• Özçelik U, Göçmen A, Kiper N, Coşkun T, Yilmaz E, Özgüç M. Sodium chloride deficiency in cystic fibrosis patients. Eur J Pediatr. 1994;153(11):829–831. doi:10.1007/BF01972892
   PubMed Web of Science ®Google Scholar
• Nichols A, Davies J, Jones D, Carr S. Restoration of exocrine pancreatic function in older children with cystic fibrosis on ivacaftor. Paediatr Respir Rev. 2020;35:99–102. doi:10.1016/j.prrv.2020.04.003
   PubMed Web of Science ®Google Scholar
• Davies JC, Wainwright CE, Sawicki GS, et al. Ivacaftor in infants aged 4 to< 12 months with cystic fibrosis and a gating mutation. Results of a two-part Phase 3 clinical trial. Am J Respir Crit Care Med. 2021;203(5):585–593. doi:10.1164/rccm.202008-3177OC
   PubMed Web of Science ®Google Scholar
• Megalaa R, Gopalareddy V, Champion E, Goralski JL. Time for a gut check: pancreatic sufficiency resulting from CFTR modulator use. Pediatr Pulmonol. 2019;54(8):E16–E18. doi:10.1002/ppul.24353
   PubMed Web of Science ®Google Scholar
• Munce D, Lim M, Akong K. Persistent recovery of pancreatic function in patients with cystic fibrosis after ivacaftor. Pediatr Pulmonol. 2020;55(12):3381–3383. doi:10.1002/ppul.25065
   PubMed Web of Science ®Google Scholar
• Ritivoiu M-E, Drăgoi CM, Matei D, et al. Current and Future Therapeutic Approaches of Exocrine Pancreatic Insufficiency in Children with Cystic Fibrosis in the Era of Personalized Medicine. Pharmaceutics. 2023;15(1):162. doi:10.3390/pharmaceutics15010162
   PubMed Web of Science ®Google Scholar
• Davies JC, Sermet-Gaudelus I, Naehrlich L, et al. A phase 3, double-blind, parallel-group study to evaluate the efficacy and safety of tezacaftor in combination with ivacaftor in participants 6 through 11 years of age with cystic fibrosis homozygous for F508del or heterozygous for the F508del-CFTR mutation and a residual function mutation. J Cystic Fibrosis. 2021;20(1):68–77. doi:10.1016/j.jcf.2020.07.023
   PubMed Web of Science ®Google Scholar
• Kapouni N, Moustaki M, Douros K, Loukou I. Efficacy and safety of elexacaftor-tezacaftor-ivacaftor in the treatment of cystic fibrosis: a systematic review. Children. 2023;10(3):554. doi:10.3390/children10030554
   PubMedGoogle Scholar
• Thompson AS, Giri N, Gianferante DM, et al. Shwachman Diamond syndrome: narrow genotypic spectrum and variable clinical features. Pediatr Res. 2022;92(6):1671–1680. doi:10.1038/s41390-022-02009-8
   PubMed Web of Science ®Google Scholar
• McLennan TW, Steinbach HL. Shwachman’s syndrome: the broad spectrum of bony abnormalities. Radiology. 1974;112(1):167–173. doi:10.1148/112.1.167
   PubMed Web of Science ®Google Scholar
• Mehta DI, Wang HH, Akins RE, Wang L, Proujansky R. Isolated pancreatic amylase deficiency: probable error in maturation. J Pediatr. 2000;136(6):844–846. doi:10.1016/S0022-3476(00)96936-1
   PubMed Web of Science ®Google Scholar
• Schwarzenberg SJ, Uc A, Zimmerman B, et al. Chronic pancreatitis: pediatric and adult cohorts show similarities in disease progress despite different risk factors. J Pediatr Gastroenterol Nutr. 2019;68(4):566–573. doi:10.1097/MPG.0000000000002279
   PubMed Web of Science ®Google Scholar
• Schwarzenberg SJ, Bellin M, Husain SZ, et al. Pediatric chronic pancreatitis is associated with genetic risk factors and substantial disease burden. J Pediatr. 2015;166(4):890–896. e891. doi:10.1016/j.jpeds.2014.11.019
   PubMed Web of Science ®Google Scholar
• Abu-El-Haija M, Hornung L, Ellery K, et al. Bone health in children with recurrent and chronic pancreatitis: a multi-center cross sectional analysis. Pancreatology. 2023. doi:10.1016/j.pan.2023.08.006
   Web of Science ®Google Scholar
• Mohan V, Premalatha G, Pitchumoni C. Tropical chronic pancreatitis: an update. J Clin Gastroenterol. 2003;36(4):337–346. doi:10.1097/00004836-200304000-00012
   PubMed Web of Science ®Google Scholar
• Liu QY, Abu-El-Haija M, Husain SZ, et al. Risk factors for rapid progression from acute recurrent to chronic pancreatitis in children: report from INSPPIRE. J Pediatr Gastroenterol Nutr. 2019;69(2):206–211. doi:10.1097/MPG.0000000000002405
   PubMed Web of Science ®Google Scholar
• Párniczky A, Abu-El-Haija M, Husain S, et al. EPC/HPSG evidence-based guidelines for the management of pediatric pancreatitis. Pancreatology. 2018;18(2):146–160. doi:10.1016/j.pan.2018.01.001
   PubMed Web of Science ®Google Scholar